Filing Flows › Comparisons › IART vs PEN
Integra Lifesciences Holdings vs Penumbra: IART and PEN compared
Integra Lifesciences Holdings is the larger company: $411M of revenue in its latest quarter (Q3 2026) against $410M for Penumbra (Q3 2026). Penumbra is growing faster (+16% against +2% a year earlier). Penumbra is more profitable, with an operating margin of 12.4% against 4.6%.
Where the money goes: IART and PEN
Integra Lifesciences Holdings (IART) · Q3 2026
Integra Lifesciences Holdings, Q3 2026: revenue $411M (+2% year over year), operating margin 4.6%, net earnings $14.9M, operating cash flow $96.0M. The chart follows the revenue to costs, profit and cash.
Penumbra (PEN) · Q3 2026
Penumbra, Q3 2026: revenue $410M (+16% year over year), operating margin 12.4%, net earnings $42.3M, operating cash flow $41.5M. The chart follows the revenue to costs, profit and cash.
| Integra Lifesciences Holdings (IART) | Penumbra (PEN) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $411M | $410M |
| Revenue growth, Y/Y | +2% | +16% |
| Gross margin | — | 68.3% |
| Operating margin | 4.6% | 12.4% |
| Net earnings | $14.9M | $42.3M |
| Net margin | 3.6% | 10.3% |
| Operating cash flow | $96.0M | $41.5M |
| Free cash flow | $85.7M | $26.4M |
| Market value | $1.1B | $12.6B |
| P/E | 83.9× | 80.4× |
| Analysts’ mean target | $15.67 | $362.54 |
Where the revenue comes from
Integra Lifesciences Holdings
- Specialty Surgery: $304M (74%)
- Tissue Reconstruction: $107M (26%)
Penumbra
- Thrombectomy: $279M (68%)
- Embolization and Access: $131M (32%)
Questions
Which is bigger, Integra Lifesciences Holdings or Penumbra?
Integra Lifesciences Holdings is the larger company: $411M of revenue in its latest quarter (Q3 2026) against $410M for Penumbra (Q3 2026).
Is Integra Lifesciences Holdings or Penumbra growing faster?
Penumbra is growing faster (+16% against +2% a year earlier).
Which is more profitable, Integra Lifesciences Holdings or Penumbra?
Penumbra is more profitable, with an operating margin of 12.4% against 4.6%.
More: Integra Lifesciences Holdings earnings · how Integra Lifesciences Holdings makes money · Penumbra earnings · how Penumbra makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 23, 2026; 10-Q filed Oct 29, 2026). Fiscal quarters can end on different dates. Not investment advice.